Michael Korrer

489 total citations
16 papers, 361 citations indexed

About

Michael Korrer is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Michael Korrer has authored 16 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Michael Korrer's work include Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Michael Korrer is often cited by papers focused on Immune Cell Function and Interaction (8 papers), CAR-T cell therapy research (5 papers) and Cancer Immunotherapy and Biomarkers (5 papers). Michael Korrer collaborates with scholars based in United States, Netherlands and Belgium. Michael Korrer's co-authors include Young J. Kim, Nicolai Wagtmann, Sytse J. Piersma, Sjoerd H. van der Burg, Marij J.P. Welters, Ilina Ehsan, Vanessa J. van Ham, Marjolein Sluijter, Nadine van Montfoort and Saskia J. Santegoets and has published in prestigious journals such as Cell, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Michael Korrer

16 papers receiving 358 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Korrer United States	7	291	197	79	21	20	16	361
Franziska Brauneck Germany	11	244 0.8×	192 1.0×	72 0.9×	12 0.6×	26 1.3×	21	387
Don G. Lee South Korea	11	251 0.9×	191 1.0×	69 0.9×	22 1.0×	9 0.5×	13	355
Javier Glez‐Vaz Spain	11	245 0.8×	229 1.2×	91 1.2×	21 1.0×	15 0.8×	17	372
Ho S. Oh South Korea	11	277 1.0×	206 1.0×	64 0.8×	22 1.0×	8 0.4×	13	377
Steven Eck United States	12	255 0.9×	153 0.8×	116 1.5×	21 1.0×	9 0.5×	20	396
Luis‐Alberto Pérez‐Quintero Canada	8	480 1.6×	184 0.9×	106 1.3×	16 0.8×	10 0.5×	12	572
Ben Wylie Australia	11	261 0.9×	167 0.8×	101 1.3×	13 0.6×	14 0.7×	18	379
Pablo Ramos Spain	10	210 0.7×	272 1.4×	62 0.8×	12 0.6×	20 1.0×	15	380
Chungyong Han South Korea	11	166 0.6×	138 0.7×	107 1.4×	16 0.8×	17 0.8×	20	309
Divij Mathew United States	8	307 1.1×	232 1.2×	143 1.8×	10 0.5×	11 0.6×	18	453

Countries citing papers authored by Michael Korrer

Since Specialization

Citations

This map shows the geographic impact of Michael Korrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Korrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Korrer more than expected).

Fields of papers citing papers by Michael Korrer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Korrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Korrer. The network helps show where Michael Korrer may publish in the future.

Co-authorship network of co-authors of Michael Korrer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Korrer. A scholar is included among the top collaborators of Michael Korrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Korrer. Michael Korrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Idrees, Kamran, et al.. (2024). Cancer Cell Small Molecule Secretome Induces the Immune Checkpoint NKG2A and Dysfunction of Human CD8+ T Cells. ImmunoHorizons. 8(6). 464–477. 1 indexed citations

Roy, Sohini, Yu Wang, Yaomin Xu, et al.. (2022). Efferocytosis drives myeloid NLRP3 dependent inflammasome signaling secretion of IL-1β to promote tumor growth. Frontiers in Immunology. 13. 993771–993771. 9 indexed citations

Taylor, David, Rupashree Sen, Juan Fu, et al.. (2022). MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses. Frontiers in Immunology. 13. 936129–936129. 3 indexed citations

Taylor, David & Michael Korrer. (2021). 581 Multi-dimensional Synergy of Combinations (MuSYC) Algorithm Optimizes Combinatorial STING and TLR Adjuvant Cancer Vaccines. SHILAP Revista de lepidopterología. A611–A611. 1 indexed citations

Kim, Young, et al.. (2020). The synergy of TLR and STING in cancer immunity. The Journal of Immunology. 204(1_Supplement). 91.30–91.30. 1 indexed citations

Korrer, Michael & Young Kim. (2019). Phenotypical and functional analysis of natural killer cells from primary human head and neck squamous cell carcinomas. The Journal of Immunology. 202(1_Supplement). 134.19–134.19. 1 indexed citations

Korrer, Michael & Young Kim. (2019). Abstract A198: The inhibitory checkpoint molecule NKG2A is upregulated on tumor-infiltrating NK cells and CD8 T-cells in human head and neck tumors. Cancer Immunology Research. 7(2_Supplement). A198–A198. 1 indexed citations

Zeng, Qi, Juan Fu, Michael Korrer, et al.. (2018). Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell–Independent Tumor Proliferation. Cancer Immunology Research. 6(5). 566–577. 23 indexed citations

Montfoort, Nadine van, Michael Korrer, Marjolein Sluijter, et al.. (2018). NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines. Cell. 175(7). 1744–1755.e15. 241 indexed citations

10.

Nixon, Mellissa J., Donna J. Hicks, Michael Korrer, et al.. (2018). Abstract 2982: Somatic TP53 mutations alter the immune microenvironmentafter chemotherapy in breast cancer. Cancer Research. 78(13_Supplement). 2982–2982. 1 indexed citations

11.

Gadkaree, Shekhar K., Juan Fu, Rupashree Sen, et al.. (2017). Induction of tumor regression by intratumoral STING agonists combined with anti–programmed death‐L1 blocking antibody in a preclinical squamous cell carcinoma model. Head & Neck. 39(6). 1086–1094. 41 indexed citations

12.

Bar‐Shir, Amnon, Michael Korrer, Hong Seo Lim, et al.. (2017). Quantification and tracking of genetically engineered dendritic cells for studying immunotherapy. Magnetic Resonance in Medicine. 79(2). 1010–1019. 13 indexed citations

13.

Korrer, Michael & Young Ho Kim. (2017). Natural Killer cells from primary human head and neck squamous cell carcinomas upregulate NKG2A. The Journal of Immunology. 198(Supplement_1). 130.18–130.18. 5 indexed citations

14.

Korrer, Michael & John M. Routes. (2015). Adenovirus serotype 5 E1A expressing tumor cells elicit a tumor-specific CD8+ T cell response independent of NKG2D. PubMed. 5. 1–5. 1 indexed citations

15.

Korrer, Michael & John M. Routes. (2014). Possible Role of Arginase-1 in Concomitant Tumor Immunity. PLoS ONE. 9(3). e91370–e91370. 11 indexed citations

16.

Kadayakkara, Deepak K., Michael Korrer, Jeff W. M. Bulte, & Hyam I. Levitsky. (2014). Paradoxical Decrease in the Capture and Lymph Node Delivery of Cancer Vaccine Antigen Induced by a TLR4 Agonist as Visualized by Dual-Mode Imaging. Cancer Research. 75(1). 51–61. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact